Nebulized Lidocaine and Intranasal Midazolam for NGT Insertion in Children
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
Nasogastric tube (NGT) is a commonly performed procedure in the Emergency Department.
Although it is not a major procedure, it is usually associated with a bad experience and
cause discomfort and pain in kids. This randomized controlled double-blinded double-dummy
trial aims to investigate the efficacy of local topical anesthetic and/or anxiolysis for
pain/anxiety related to NGT insertion. Eligible patients are children with gastroenteritis
aged 6 months to 5 years requiring NGT rehydration. The intervention are 3 arms of nebulized
lidocaine with midazolam compared to nebulized midazolam alone or placebo. The primary
outcome is procedure-related pain assessment using the Face, Legs, Activity, Cry, and
Consolability (FLACC) scale during final NGT insertion attempt.